By RefineNutrition.org Health Editorial Team
Accessing GLP-1 weight loss medications used to mean fighting for insurance approval, paying over $1,000 monthly at retail pharmacies, or waiting weeks for appointments with endocrinologists. Telehealth platforms like MEDVI have changed that equation, offering compounded semaglutide and tirzepatide through a fully remote process. But how well does this model actually work? We've gathered insights from patients, analyzed the platform's structure, and evaluated what you should know before enrolling.
How MEDVI's Telehealth Model Works
MEDVI operates differently than a traditional doctor's office. When you enroll, you're not becoming a patient of MEDVI itself—the company provides the technology platform that connects you with licensed healthcare providers who make independent prescribing decisions.
The process starts with an online health assessment. You'll answer questions about your weight, medical history, current medications, and weight loss goals. This takes about five minutes and can be done from your phone or computer at any time.
After payment, a licensed clinician from the OpenLoop Health network reviews your information. They're looking for contraindications, drug interactions, and determining if GLP-1 medication is medically appropriate for your situation. Most patients receive approval within 24-48 hours, though those needing additional evaluation may take longer.
Once approved, your prescription goes to a partner compounding pharmacy. According to platform documentation, MEDVI works with multiple U.S.-certified pharmacies to prepare and ship medications. Packages typically arrive within 3-7 days with cold packs maintaining proper storage temperature.
What Patients Say About Their Experience
Patient reviews paint a picture of what you can realistically expect from MEDVI's telehealth approach.
The enrollment process receives consistently positive feedback. Patients describe it as straightforward, quick, and less intimidating than scheduling doctor visits. One reviewer noted they'd been putting off weight loss treatment for years because of anxiety about in-person appointments, and the fully online process finally let them take action.
Customer support quality comes up frequently in reviews. MEDVI offers 24/7 access to clinical staff, and patients mention getting quick responses to questions about side effects, dosing concerns, or prescription issues. The ability to text questions rather than calling or scheduling appointments appeals to many users.
Shipping logistics occasionally frustrate patients. While most report receiving medications promptly, some reviews mention delays—particularly around holidays or during periods of high demand. The platform recommends submitting refill requests early to avoid gaps in treatment.
Weight loss results follow expected patterns. Patients who combine medication with dietary changes and increased activity report meaningful results. Those expecting the medication to work without lifestyle modifications tend to express disappointment. This aligns with clinical trial data showing that GLP-1 drugs work best as one component of a complete approach.
Medications Available Through MEDVI
The platform offers both compounded semaglutide and compounded tirzepatide, giving patients options based on their goals and budget.
Compounded Semaglutide activates GLP-1 receptors to reduce appetite and slow digestion. It's available as weekly injections ($179 first month, $299 refills) or daily dissolvable tablets ($249 first month). This is the more affordable option and a good starting point for patients new to GLP-1 therapy.
Compounded Tirzepatide activates both GLP-1 and GIP receptors, producing greater weight loss in clinical studies. Available as weekly injections ($279 first month, $399-499 refills) or oral tablets. Patients seeking maximum results often prefer this option despite the higher cost.
MEDVI also lists brand-name Ozempic starting at $1,999 monthly when supply is available, though most patients opt for compounded versions given the price difference.
Research comparing these medications shows tirzepatide achieves approximately 50% greater weight loss than semaglutide, which influences many patients' medication choice.
The Pros of MEDVI's Approach
Several aspects of MEDVI's model offer genuine advantages over traditional weight loss treatment pathways:
Accessibility: No appointments to schedule, no office visits required, no insurance authorization hoops. You can start the process at 10 PM from your couch if that's what works for your schedule.
Cost transparency: Monthly pricing includes everything—medication, provider access, shipping, and support. There are no surprise fees or hidden charges after enrollment.
Speed: Most patients go from initial assessment to medication in hand within one week. Compare that to weeks of insurance appeals or months waiting for specialist appointments.
Flexibility: Month-to-month billing with no long-term contracts. You can pause or stop treatment without penalty (though weight often returns when medication stops).
Privacy: Some patients prefer not discussing weight in person. The telehealth model offers discretion for those who value it.
Limitations to Consider
Telehealth weight loss isn't perfect for everyone, and MEDVI's model has inherent constraints:
No physical examination: Providers can't take your blood pressure, listen to your heart, or conduct other in-person assessments. For patients with complex medical conditions, this limitation matters.
Compounded medication status: The drugs MEDVI provides aren't FDA-approved as finished products. They use approved active ingredients prepared by licensed pharmacies, but haven't undergone the same rigorous testing as brand-name versions.
Relationship depth: You won't develop the long-term relationship with a provider that traditional care offers. Communication happens through messaging rather than face-to-face interaction.
Emergency limitations: If you experience serious adverse effects, MEDVI can't help with emergency care. You'd need to contact local providers or emergency services.
Who Thrives with MEDVI's Model
Based on patient feedback and program structure, certain profiles tend to report the best experiences:
Patients comfortable with technology who prefer digital interactions over office visits adapt well. Those with straightforward medical histories not requiring complex management find the telehealth model sufficient. Self-motivated individuals willing to take ownership of their health journey benefit most. Budget-conscious patients who can't afford brand-name medications appreciate the cost savings. People with demanding schedules who struggle to fit traditional appointments into their day value the flexibility.
Who Might Need Different Options
Some patients may be better served by other approaches:
Those with complex medical conditions like unstable heart disease, advanced kidney disease, or severe diabetes often need closer monitoring. Patients who value face-to-face provider relationships may find telehealth unsatisfying. People requiring extensive emotional support for weight loss might benefit from in-person programs. Those uncomfortable with the compounded medication framework may prefer FDA-approved options.
Getting Started with MEDVI
If you're considering MEDVI, here's what to expect:
Visit medvi.org and complete the health assessment. Have your medical history and current medication list available. Submit payment after completing the assessment—this doesn't guarantee prescription approval, which depends on clinical evaluation.
Wait for provider review, typically 24-48 hours. If approved, your prescription goes to a partner pharmacy. Expect medication delivery within 3-7 days.
Current program details and pricing are available on the website, or you can contact support at (323) 690-1564 or help@medvi.org with questions.
Managing Expectations
GLP-1 medications aren't magic, and telehealth platforms aren't shortcuts. Weight loss requires sustained effort—medication makes that effort more effective by reducing hunger and food noise, but it won't work without your participation.
Expect side effects, especially when starting or increasing doses. Nausea is nearly universal; have ginger tea or bland foods ready. Plan to adjust your eating patterns—the medication reduces appetite, so you'll need to focus on nutrition quality even as quantity decreases.
Most patients see meaningful results within 2-3 months if they're committed to the program. If you're not seeing progress after following protocols for several months, communicate with your provider about adjustments.
Disclaimer: This article provides general information and isn't medical advice. Telehealth services can't replace in-person care for all patients. Consult a qualified healthcare provider before starting any weight loss medication. Individual results vary, and compounded medications aren't FDA-approved as finished products.